← Leaderboards
Carol A. Nacy
Sequella Global Tuberculosis Foundation
$6,694,053
Attributed
$6,694,053
Total exposure
8
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $736.4K · FY2005–13$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$6,694,053 · 8
By mechanism
R44$1,972,752 · 1
U01$1,894,528 · 1
UC1$1,361,370 · 1
R43$959,594 · 3
R01$479,809 · 1
RC1$26,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Mycobacterium Tuberculosis”
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$267,251,837
- Constance Ann Benson · University Of California, San Diego$150,079,712
- Kevin Urdahl · Seattle Children'S Hospital$86,597,961
- David Alland · Rutgers Biomedical And Health Sciences$70,943,567
- Sarah Fortune · Harvard School Of Public Health$51,119,645
- William Robert Jacobs · Albert Einstein College Of Medicine$43,123,310
Research focus
Mycobacterium TuberculosisTuberculosisDiagnosis Design /EvaluationBiotechnologyAntitubercular AgentsHigh Throughput TechnologyBioterrorism /Chemical WarfareDrug Screening /EvaluationClinical Trial Phase IClinical Trial Phase IiEthambutolGenetic TechniquesHuman SubjectMicroorganism CultureTransfection /Expression VectorPatient Oriented ResearchBacterial ProteinsRapid DiagnosisBacterial GeneticsDiagnosis Quality /StandardCombinatorial ChemistryCooperative StudyBacterial AntigensTransdermal Drug Delivery
Grant awards (15)
A New Therapeutic Regimen for MDR-TB$297,897
R43 · FY2013 · AI · contact PI
A New Therapeutic Regimen for MDR-TB$267,444
R43 · FY2012 · AI · contact PI
A Second-Generation Patch Test for Tuberculosis$299,160
U01 · FY2006 · AI · contact PI
A Second-Generation Patch Test for Tuberculosis$736,439
U01 · FY2005 · AI
Advancing a new TB drug through early clinical trials$1,361,370
UC1 · FY2004 · AI
A Rapid Lateral Flow Test for TB in Nonhuman Primates$986,376
R44 · FY2004 · RR
A Second-Generation Patch Test for Tuberculosis$621,250
U01 · FY2004 · AI
A Rapid Lateral Flow Test for TB in Nonhuman Primates$986,376
R44 · FY2003 · RR
A Second-Generation Patch Test for Tuberculosis$237,679
U01 · FY2003 · AI
High throughput TB drug screens$172,765
R01 · FY2003 · AI
High throughput TB drug screens$157,044
R01 · FY2002 · AI
Transdermal Test for Active Tuberculosis$232,038
R43 · FY2001 · AI
A Rapid Lateral Flow Test for TB in Nonhuman Primates$162,215
R43 · FY2001 · AI
High throughput TB drug screens$150,000
R01 · FY2001 · AI
GENE-BASED AND BACTERIA HIGH THROUGHOUT TB DRUG SCREEN$26,000
RC1 · FY2000 · AI